Samalin Investment Counsel, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Samalin Investment Counsel, LLC

  • $207 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$83.14 - $145.99 $6,651 - $11,679
-80 Closed
0 $0
Q4 2021

Feb 15, 2022
BUY
$99.73 - $148.48 $1,994 - $2,969
20 Added 33.33%
80 $11 Million
Q3 2021

Nov 15, 2021
SELL
$98.85 - $138.91 $7,908 - $11,112
-80 Reduced 57.14%
60 $8.34 Million
Q2 2021

Aug 12, 2021
BUY
$65.78 - $105.02 $9,209 - $14,702
140 New
140 $13,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Samalin Investment Counsel, LLC Portfolio

Follow Samalin Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samalin Investment Counsel, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email